Review Article

Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction

Table 1

Clinical trials of MSC transplantation for treating MI.

Clinical trialsPhaseDose (106)Delivery routeEnrollmentInfarct scarLVEFFollowing upStudyReference

NCT00114452Phase 10.5/1.6/5IC53n.a.6 mHare et al. (2009)[25]
NCT00677222Phase 1100IC30n.a.4 mPenn et al. (2012)[26]
2011AA020109Phase 13.08IC43=12 mGao et al. (2013)[27]
UO1 HL087318–04Phase 1150IC6512 mTraverse et al. (2014)[28]
NCT01234181Phase 1100IC2212 mHu et al. (2015)[29]
NCT01087996Phase 1/220IM3013 mHare et al. (2012)[30]
U54HL081028Phase 1/220IM3013 mSuncion et al. (2014)[31]
NCT02323477Phase 1/220IM79n.a.n.a.12 mCan et al. (2015)[32]
NCT00883727Phase 1/2180–220IV20==2 yChullikana et al. (2015)[33]
NCT02504437Phase 1/220012 mPei (2015–2017)ClinicalTrials.gov
NCT02503280Phase 1/22005512 mJoshua (2015–2032)ClinicalTrials.gov
NCT02666391Phase 1/26418 mPei (2016–2017)ClinicalTrials.gov
NCT01770613Phase 212 mNabil (2013–2017)ClinicalTrials.gov
NCT00684021Phase 2150IC101n.a.6 mSchutt et al. (2015)[34]
NCT00984178Phase 215IC12012 mSan Roman et al. (2015)[35]
NCT00765453Phase 259.8IC100n.a.12 mChoudry et al. (2015)[36]
NCT01291329Phase 26IC11618 mGao et al. (2015)[37]
NCT03047772Phase 212412 mYang (2017–2018)ClinicalTrials.gov
NCT00877903Phase 2IV2205 yDonna (2009–2018)ClinicalTrials.gov
NCT02013674Phase 2100IM3012 mFlorea et al. (2013–2019)[38]
NCT01392105Phase 2/372IC80n.a.6 mLee et al. (2014)[39]
NCT03404063Phase 2/3301156 mPiotr (2017–2020)ClinicalTrials.gov
NCT01394432Phase 3IM5012 mEvgeny (2012–2016)ClinicalTrials.gov
NCT01652209Phase 313513 mYang (2013–2020)ClinicalTrials.gov
NCT02672267Phase 3IM506 mSaule (2014–2016)ClinicalTrials.gov

MSCs: mesenchymal stem cells; MI: myocardial infarction; IM: intramyocardial; IC: intracoronary; IV: intravenous; LVEF: left ventricular ejection fraction; y: year; m: month; n.a.: not analyzed; =: no statistical significance. , , and .